Effect of a Maintenance Protocol After Surgical Treatment of Peri-implantitis
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
This study was designed as a 12-month, two arms, randomized clinical trial to evaluate the efficacy of a supportive treatment protocol (SPIT). Thirty patients were randomized, six months after access-flap surgery, in two different SPIT groups. After ultrasonic debridement, the affected implant surfaces of the test group were treated with glycine powder air-polishing, while implants in the control group a rubber cup and polishing paste was used. Maintenance visits were carried every 3 months and clinical, radiological, microbiological and biochemical variables were registered at baseline (6 months after surgery) and after a follow-up period of 12 months (18 months after surgery).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 10, 2022
CompletedOctober 10, 2022
September 1, 2022
8.6 years
September 26, 2022
October 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Probing Pocket Depth
Changes in Probing Pocket Depth measured in milimeters with a manual periodontal probe
Baseline, 6 and 18 months after the surgical procedure
Secondary Outcomes (10)
Distance of Gingival Recession
Baseline, 6 and 18 months after the surgical procedure
Bleeding on Probing index
Baseline, 6 and 18 months after the surgical procedure
Plaque Index
Baseline, 6 and 18 months after the surgical procedure
Suppuration Index
Baseline, 6 and 18 months after the surgical procedure
Radiographic bone loss distance measured from the prosthetic connection platform to the bottom of the intraosseous defect
Baseline, 6 and 18 months after the surgical procedure
- +5 more secondary outcomes
Study Arms (2)
Glycine - Test
EXPERIMENTALPolishing treatment with glycine powder air-polishing after ultrasonic plaque debridement.
Rubber cup - Control
ACTIVE COMPARATORPolishing treatment with a rubber cup and polishing paste after ultrasonic debridement
Interventions
Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant. Then, the implants were treated with glycine powder air-polishing.
Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant. Then, the implants were treated with rubber cup and a polishing paste.
Eligibility Criteria
You may qualify if:
- Presence of at least one implant with peri-implantitis, defined as: radiographic evidence of bone loss \>2 mm, inflammation of the peri-implant mucosa as defined by positive BoP and/or suppuration, and at least one site with PD ≥ 5 mm.
- Based on the radiographic examination, the affected implant should not have a vertical peri-implant defect. Positive selection was based on the presence of pe-ri-implant lesions wider than 4 mm, with an angle greater than 35 º.
- In patients with a history of periodontitis, periodontal therapy should have been provided at least 6 months prior to the initiation of the study.
You may not qualify if:
- Presence of relevant medical conditions and/or systemic medications that would contraindicate the surgical procedure or modify the tissue response after therapy.
- Patients requiring antibiotic prophylaxis.
- Heavy smokers (\> 10 cigarettes/day).
- Pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2022
First Posted
October 10, 2022
Study Start
January 1, 2013
Primary Completion
August 1, 2021
Study Completion
August 1, 2021
Last Updated
October 10, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share